Division of Rheumatology / Endocrinology / Gastroenterology: Research and Laboratories
Through clinical research we are helping discover which medications might be best for patients with many diseases. We are also investigating new therapies which may be released in the future. Many of our disease are related to problems with immune system, and many of the new therapies are directed towards helping rectify these subtle abnormalities. Our division is particularly interested in these types of problem and we are relentless in the search for the best treatment for each patient.
Current research initiatives include:
- A Randomized, Double-Blind, Parallel Group, International Study to Evaluate the Safety and Efficacy of Ocrelizumab Compared to Placebo in Patients with Active Rheumatoid Arthritis Continuing Methotrexate-Treatment Phase. Funded by Genentech Incorporated.
- A Long Term Study of the Safety of Rituxan in Patients with Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE) Funded by Genentech Incorporated.
Clinical Trials
All members of our division are enthusiastic about conducting clinical research. We are already participating in many clinical trials, and there are several more which are ready to begin soon. The clinical trials are directed at finding the best treatments for various manifestations of our diseases. Often, these investigate new medications and their effect on specific diseases.
Search for current clinical trials at National Jewish Health.
Learn about education opportunities related to the Division of Rheumatology / Endocrinology / Gastroenterology.
